Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 28, 2009 10:00 ET | Source: Infinity Pharmaceuticals, Inc.

Infinity Announces First Quarter 2009 Results Conference Call

CAMBRIDGE, Mass., April 28, 2009 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced that Infinity management...
April 21, 2009 15:00 ET | Source: Infinity Pharmaceuticals, Inc.

Infinity Presents New Preclinical Data From Its Heat Shock Protein 90 Inhibitor Program At AACR

DENVER, Colo. and CAMBRIDGE, Mass., April 21, 2009 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI) today presented data from its heat shock protein 90 (Hsp90) inhibitor program that...
April 21, 2009 10:00 ET | Source: Infinity Pharmaceuticals, Inc.

Infinity Presents Preclinical Data Demonstrating Potential of Hedgehog Pathway Inhibition With IPI-926 in Multiple Cancer Settings

DENVER and CAMBRIDGE, Mass., April 21, 2009 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI) today presented preclinical data from studies of IPI-926, its oral Hedgehog pathway...
April 15, 2009 09:15 ET | Source: Infinity Pharmaceuticals, Inc.

Infinity Halts RING Trial in Advanced Gastrointestinal Stromal Tumors

-- Decision Based On Recommendation Received Tuesday Night From Independent Data Monitoring Committee -- -- Infinity Reaffirms Commitment to Hsp90 Development and Cash ...
April 08, 2009 06:30 ET | Source: Infinity Pharmaceuticals, Inc.

Infinity to Present Preclinical Data From Its Hsp90 Inhibitor Program and Its Hedgehog Signaling Pathway Inhibitor Program At AACR Meeting

CAMBRIDGE, Mass., April 8, 2009 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced that it will be reporting...
April 07, 2009 06:30 ET | Source: Infinity Pharmaceuticals, Inc.

Infinity Announces Leadership Promotions

CAMBRIDGE, Mass., April 7, 2009 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced two leadership...
March 30, 2009 06:30 ET | Source: Infinity Pharmaceuticals, Inc.

Infinity Initiates International Phase 2 Trial of IPI-504 in Combination With Herceptin(r) in Patients With HER2-Positive Breast Cancer

CAMBRIDGE, Mass., March 30, 2009 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced the initiation of a...
March 25, 2009 11:00 ET | Source: Infinity Pharmaceuticals, Inc.

Infinity Presents the Chemistry and Discovery of IPI-926, Its Novel Hedgehog Signaling Pathway Inhibitor, At ACS Meeting

CAMBRIDGE, Mass. and SALT LAKE CITY, March 25, 2009 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced data...
March 23, 2009 07:30 ET | Source: Infinity Pharmaceuticals, Inc.

Infinity to Present At the Future Leaders Conference

CAMBRIDGE, Mass., March 23, 2009 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced that Steven H. Holtzman,...
March 17, 2009 07:30 ET | Source: Infinity Pharmaceuticals, Inc.

Infinity to Present the Discovery of IPI-926, Its Hedgehog Signaling Pathway Inhibitor, At ACS Meeting

CAMBRIDGE, Mass., March 17, 2009 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced that it will be...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right